Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study

2017 ◽  
Vol 57 (10) ◽  
pp. 1507-1521 ◽  
Author(s):  
Richard B. Lipton ◽  
Michael L. Reed ◽  
Tobias Kurth ◽  
Kristina M. Fanning ◽  
Dawn C. Buse
Keyword(s):  
Cardiovascular Risk ◽  
Episodic Migraine ◽  
Migraine Prevalence ◽  
Risk Estimates ◽  
The Us

Examination of Unmet Treatment Needs Among Persons With Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study

2013 ◽  
Vol 53 (8) ◽  
pp. 1300-1311 ◽  
Author(s):  
Richard B. Lipton ◽  
Dawn C. Buse ◽  
Daniel Serrano ◽  
Starr Holland ◽  
Michael L. Reed
Keyword(s):  
Episodic Migraine ◽  
Treatment Needs ◽  
Migraine Prevalence

Factors Associated With Triptan Use in Episodic Migraine: Results From the American Migraine Prevalence and Prevention Study

2011 ◽  
Vol 52 (2) ◽  
pp. 213-223 ◽  
Author(s):  
Min Kyung Chu ◽  
Dawn C. Buse ◽  
Marcelo E. Bigal ◽  
Daniel Serrano ◽  
Richard B. Lipton
Keyword(s):  
Episodic Migraine ◽  
Prevention Study ◽  
Factors Associated ◽  
Migraine Prevalence

scholarly journals Arsenic in Drinking Water and Lung Cancer Mortality in the United States: An Analysis Based on US Counties and 30 Years of Observation (1950–1979)

2016 ◽  
Vol 2016 ◽  
pp. 1-13 ◽  
Author(s):  
Hamid Ferdosi ◽  
Elisabeth K. Dissen ◽  
Nana Ama Afari-Dwamena ◽  
Ji Li ◽  
Rusan Chen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Drinking Water ◽  
Cancer Risk ◽  
Lung Cancer Risk ◽  
The United States ◽  
Risk Estimates ◽  
Unit Risk ◽  
The Us ◽  
Us Epa ◽  
Us Counties

Background.To examine whether the US EPA (2010) lung cancer risk estimate derived from the high arsenic exposures (10–934 µg/L) in southwest Taiwan accurately predicts the US experience from low arsenic exposures (3–59 µg/L).Methods. Analyses have been limited to US counties solely dependent on underground sources for their drinking water supply with median arsenic levels of ≥3 µg/L.Results. Cancer risks (slopes) were found to be indistinguishable from zero for males and females. The addition of arsenic level did not significantly increase the explanatory power of the models. Stratified, or categorical, analysis yielded relative risks that hover about 1.00. The unit risk estimates were nonpositive and not significantly different from zero, and the maximum (95% UCL) unit risk estimates for lung cancer were lower than those in US EPA (2010).Conclusions. These data do not demonstrate an increased risk of lung cancer associated with median drinking water arsenic levels in the range of 3–59 µg/L. The upper-bound estimates of the risks are lower than the risks predicted from the SW Taiwan data and do not support those predictions. These results are consistent with a recent metaregression that indicated no increased lung cancer risk for arsenic exposures below 100–150 µg/L.

Treatment and Management of Migraine—The Road Ahead

US Neurology ◽  
2009 ◽  
Vol 05 (01) ◽  
pp. 72
Author(s):  
Susan L Hutchinson ◽  
Stewart J Tepper ◽  
◽  
Keyword(s):  
Episodic Migraine ◽  
Phase Iii ◽  
Migraine Treatment ◽  
Glutamate Antagonists ◽  
The Road ◽  
Calcitonin Gene ◽  
The Us ◽  
The Future ◽  
Phase Iii Trials ◽  
Daily Headache

The road ahead for migraine treatment depends on targeting pharmacological therapies to known pathophysiological mechananisms. Acute medications of the future may include calcitonin gene-related peptide antagonists, various glutamate antagonists, and serotonin 1F receptor agonists. New formulations of older medications include effervescent diclofenac, an orally inhaled dihydroergotamine, and sumatriptan iontophoretic patch and needless injection, all either approved in the US or in phase III trials. Preventive future treatments may include the use of botulinum neurotoxin type A for chronic daily headache and gabapentin enacarbil for episodic migraine, in addition to hormonal treatments and a potential for neuromodulators, but the preventive pipeline is far less developed. In the US, the United Council for Neurologic Subspecialty Board certification for headache medicine should raise quality of care and research in the future.

Cardiovascular Risk Estimates and Risk Factors in Renal Transplant Recipients

2005 ◽  
Vol 37 (4) ◽  
pp. 1868-1870 ◽  
Author(s):  
B.K. Krämer ◽  
C. Böger ◽  
B. Krüger ◽  
J. Marienhagen ◽  
M. Pietrzyk ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Risk ◽  
Renal Transplant ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Risk Estimates

PM249 Cardiovascular Risk Estimates Among Newly Presenting African Hypertensives

Global Heart ◽  
2014 ◽  
Vol 9 (1) ◽  
pp. e112
Author(s):  
Abiodun M. Adeoye ◽  
Mirabel Nwosu ◽  
Adewole Adebiyi ◽  
Olulola Oladapo ◽  
Ayodele Falase
Keyword(s):  
Cardiovascular Risk ◽  
Risk Estimates
Sign in / Sign up

Export Citation Format

Share Document